Chemotherapy by investigator's choice
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Chemotherapy by investigator's choice, covering 2025-06-04 to 2025-06-04. Get the full timeline:
Most recent: Clinical Trial Update: FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration [Phase 3]